We demonstrated that mild cognitive impairment (MCI) participants of the ADNI database (N=640)can be discriminated into 3 coherent and neuropsychologically-defined subgroups. Our clusteringapproach revealed an amnestic MCI, a mixed MCI and a false positive subgroup. Furthermore, weinvestigated the neurobiological foundation of these automatically extracted MCI subgroups.Classification modelling exposed that specific predictive features can be used to differentiateamnestic and mixed MCI from healthy controls: CSF Aβ1-42 concentration for the former and CSF Aβ1-42concentration, tau concentration as well as cortical atrophies (especially in the temporal and occipitallobes) for the latter. In contrast, false positive participants exhibited an i...
Background: Unraveling novel biomarkers for mild cognitive impairment (MCI) was highlighted in the p...
Background: Amnestic Mild cognitive impairment (aMCI) is considered to be the transitional stage bet...
Objectives: Neuropsychiatric symptoms are common in subjects with MCI and associated with higher ris...
We demonstrated that mild cognitive impairment (MCI) participants of the ADNI database (N=640)can be...
ObjectiveWe investigated differences in regional cortical thickness between previously identified em...
BackgroundWe assessed whether mild cognitive impairment (MCI) subtypes could be empirically derived ...
ObjectivesResearch demonstrates heterogeneous neuropsychological profiles among individuals with mil...
Background and objectivesGiven prior work demonstrating that mild cognitive impairment (MCI) can be ...
Objective: Given prior work demonstrating that mild cognitive impairment (MCI) can be empirically di...
International audienceFew studies have examined the relationship between CSF and structural biomarke...
ObjectiveWe previously identified 4 empirically derived mild cognitive impairment (MCI) subtypes via...
We compared two methods of diagnosing mild cognitive impairment (MCI): conventional Petersen/Winblad...
ObjectiveWe studied the biomarker signatures and prognoses of 3 different subtle cognitive impairmen...
Objective: We studied the biomarker signatures and prognoses of 3 different subtle cognitive impairm...
Alzheimer’s Disease (AD) and mild cognitive impairment (MCI) are associated with widespread changes ...
Background: Unraveling novel biomarkers for mild cognitive impairment (MCI) was highlighted in the p...
Background: Amnestic Mild cognitive impairment (aMCI) is considered to be the transitional stage bet...
Objectives: Neuropsychiatric symptoms are common in subjects with MCI and associated with higher ris...
We demonstrated that mild cognitive impairment (MCI) participants of the ADNI database (N=640)can be...
ObjectiveWe investigated differences in regional cortical thickness between previously identified em...
BackgroundWe assessed whether mild cognitive impairment (MCI) subtypes could be empirically derived ...
ObjectivesResearch demonstrates heterogeneous neuropsychological profiles among individuals with mil...
Background and objectivesGiven prior work demonstrating that mild cognitive impairment (MCI) can be ...
Objective: Given prior work demonstrating that mild cognitive impairment (MCI) can be empirically di...
International audienceFew studies have examined the relationship between CSF and structural biomarke...
ObjectiveWe previously identified 4 empirically derived mild cognitive impairment (MCI) subtypes via...
We compared two methods of diagnosing mild cognitive impairment (MCI): conventional Petersen/Winblad...
ObjectiveWe studied the biomarker signatures and prognoses of 3 different subtle cognitive impairmen...
Objective: We studied the biomarker signatures and prognoses of 3 different subtle cognitive impairm...
Alzheimer’s Disease (AD) and mild cognitive impairment (MCI) are associated with widespread changes ...
Background: Unraveling novel biomarkers for mild cognitive impairment (MCI) was highlighted in the p...
Background: Amnestic Mild cognitive impairment (aMCI) is considered to be the transitional stage bet...
Objectives: Neuropsychiatric symptoms are common in subjects with MCI and associated with higher ris...